Azofend 200 mg Tablet is a potent azole antifungal medication specifically designed to treat a wide range of serious fungal infections in adults and adolescents aged 12 years and older. Containing Voriconazole, a triazole antifungal, Azofend 200 mg works by inhibiting fungal cytochrome P450-dependent 14-alpha sterol demethylase, a crucial enzyme in the biosynthesis of ergosterol. Ergosterol is an essential component of the fungal cell membrane; its depletion disrupts cell membrane integrity, resulting in inhibition of fungal growth and eventual cell death.
Azofend is particularly effective against invasive aspergillosis, disseminated candidiasis, candidemia, esophageal candidiasis, and severe infections caused by Fusarium species and Scedosporium apiospermum, including strains resistant or intolerant to alternative antifungal treatments. Its broad-spectrum activity makes it a critical choice in the management of life-threatening fungal infections, particularly in immunocompromised patients.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Other Antifungal Preparations
Triazole Antifungal
Azofend 200 mg selectively inhibits fungal CYP450 14-alpha sterol demethylase, preventing the conversion of lanosterol to ergosterol. The resulting accumulation of 14-alpha-methyl sterols destabilizes the fungal cell membrane, reducing fungal proliferation. Azofend has greater selectivity for fungal CYP450 enzymes compared to mammalian enzymes, which minimizes systemic toxicity.
Azofend 200 mg is indicated for the treatment of:
Invasive Aspergillosis
Disseminated Candidiasis and Candidemia in skin, abdominal organs, kidneys, bladder wall, and wounds (non-neutropenic)
Esophageal Candidiasis
Severe Fusarium infections (Fusarium solani)
Scedosporium apiospermum infections
Cases resistant to or intolerant of alternative antifungal treatments
It is recommended for patients aged 12 years and older under strict medical supervision.
Oral Administration:
Take tablets or suspension at least 1 hour before or 1 hour after meals
≥40 kg body weight: Loading dose 400 mg (10 ml) every 12 hours for the first 24 hours; maintenance 200 mg (5 ml) twice daily
<40 kg body weight: Loading dose 200 mg (5 ml) every 12 hours for 24 hours; maintenance 100 mg (2.5 ml) twice daily
Intravenous Administration:
Invasive Aspergillosis: Loading 6 mg/kg every 12 hours for 24 hours; maintenance 4 mg/kg every 12 hours
Candidemia and other deep tissue Candida infections: Loading 6 mg/kg every 12 hours for 24 hours; maintenance 3–4 mg/kg every 12 hours
Scedosporiosis and Fusariosis: Loading 6 mg/kg every 12 hours for 24 hours; maintenance 4 mg/kg every 12 hours
Duration of therapy depends on clinical and mycological response. Long-term exposure beyond 180 days requires careful benefit-risk assessment.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Monitor liver function during prolonged therapy
Use caution in severe hepatic impairment; adjust maintenance dose as necessary
Avoid co-administration with drugs causing significant CYP3A4, CYP2C9, and CYP2C19 interactions
Not recommended for pregnant women unless benefit clearly outweighs risk
Safety and efficacy in children under 12 years not established
Prolonged use linked to rare reports of squamous cell carcinoma
Common adverse effects may include:
Abdominal pain, nausea, diarrhea
Headache, visual disturbances
Anemia, chest pain
Serious but rare effects include hepatotoxicity and severe allergic reactions.
Store below 25°C in a dry, dark place
Suspension: refrigerate at 2–8°C
Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet